Published in Pharma Law Weekly, July 14th, 2009
"The primary focus is on interventions assessed in systematic reviews and meta-analyses of randomized trials," wrote L.L. Gluud and colleagues, Gentofte University.
The researchers concluded: "The interventions assessed include active and passive immunization for hepatitis A and B and treatments for hepatitis B and C. The results of meta-analyses on conventional interferon-alpha, pegylated interferon alpha, lamivudine, adefovir, and interferon plus ribavirin are summarized."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.